written by reader $ANAC…Anacor and small cap Biomed stocks

by hendrixnuzzles | April 13, 2015 4:25 pm

CALLING FOR BORON BIGFOOT

$ANAC Gosh I really need this…anyone else got toe fungus ?
ANACOR was approved last fall for selling us a topical treatment for toe fungus based on boron[1] chemistry. Don’t laugh, they said 35 million Americans suffer from toenail fungus. And it is often on more than one toe.

Anacor specializes in the use of boron as a base compound for medicines. They say the advantage is that since the geometry of the boron atoms are unique, the shapes and impact of boron molecular
compounds have novel and different impacts on pathogenic cells compared to conventionally used compounds formulated with carbon.

Also there are pathogens that are difficult to suppress by conventional carbon-based compounds; but boron-based medicines will be able to effective treat some of these pathogens.

They also note that the competitive field is fairly light on atomic boron specialists.

They also say that they have solved the problem of large-scale commercial production of boron compounds formulated for medical products.

The toenail medicine in the market already and they are coming up with another topical drug for psoriasis[2]. The sold off the rights to a veterinary drug to Eli Lilly and will be getting milestones and
royalties from it, they already got a million or two. The price of the stock is over $ 60, so it’s a ”real” stock.

What I am wondering about is …if they have already produced two or three medicines using this boron technology, and there have not been unforeseen repercussions, then it seems there is a very
large playing field ahead of them without a lot of players on it. Lots of royalties and sales of patented boron compounds.

Or maybe someone knows of a competitor using a different element like kryptonite or Xenon to produce medicial compounds ?

I’d like to get a feel for the potential of boron therapies getting my toe in the water[3]. Anybody got an opinion on the science end of this ?

Endnotes:
  1. boron: https://www.stockgumshoe.com/tag/boron/
  2. psoriasis: https://www.stockgumshoe.com/tag/psoriasis/
  3. water: https://www.stockgumshoe.com/tag/water/

Source URL: https://www.stockgumshoe.com/2015/04/microblog-anac-anacor-and-small-cap-biomed-stocks/


6 responses to “written by reader $ANAC…Anacor and small cap Biomed stocks”

  1. SoGiAm says:

    Hi, hendrixnuzzles- Boron is used in many therapies as evidenced here: http://www.webmd.com/vitamins-supplements/ingredientmono-894-boron.aspx?activeingredientid=894&activeingredientname=boron
    Conditions & Treatments Related to boron
    Arthritis Treatments
    Cognitive function Treatments
    Athletic conditioning Treatments
    Bacterial vaginosis Treatments
    Athletic performance Treatments
    Boron deficiency Treatments
    Candida Treatments
    Candida albicans Treatments
    Candidiasis Treatments
    Low bone density Treatments
    Osteoarthritis Treatments
    Osteoarthritis and rheumatoid arthritis Treatments
    Osteoporosis Treatments
    Trichomonas vaginitis Treatments
    Vaginal candidiasis Treatments
    Vulvovaginitis Treatments
    Yeast infection Treatments
    I might also add, I believe it is the main ingredient in Harris Roach Tablets http://pfharris.com/ …being from the South, I know they work 🙂 Best-Benjamin

  2. hendrixnuzzles says:

    $ ANAC Thanks again, Ben. Boron as an element has been used in medicine for many years but what seems to be relatively recent is the use of complex molecules that use
    boron as a base molecule instead of carbon. There is a very good article published by NIH titled “Not boring at all. Boron is the new carbon” that outlines the reason boron is interesting and the potential for greatly expanded use of boron-based molecular compounds.

    The article states that boron research is accelerating and cites the $2.5 billion boron investment by GSK in 2008…they took a position in ANAC, and the takeover in 2008
    of Millenium Pharma by Takeda.

    Going to go back to the Anacor website for more detail. Looks more interesting than before.

  3. hendrixnuzzles says:

    Interesting that GSK’s 2008 investment in ANAC for a partial stake in the company is about the same as ANAC’s current market cap. So ANAC is a pretty good value or GSK made a bad
    bet….

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.